PREVENTIVE EFFECT OF ANTI-VIRAL THERAPY ON THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C OR B: A META-REGRESSION APPROACH

被引：0
|
作者：
Cheng, C. C. [1 ,2 ]
Shen, Y. C. [1 ,2 ,3 ]
Hsu, C. [1 ,3 ]
Hu, F. C. [1 ,2 ]
Cheng, A. L. [1 ,3 ,4 ]
机构：
[1] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Oncol, Taipei 100, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60250-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [1] A Critical Evaluation of the Preventive Effect of Antiviral Therapy on the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C or B: A Novel Approach by Using Meta-Regression
    Shen, Ying-Chun
    Hsu, Chiun
    Cheng, Chia-Chi
    Hu, Fu-Chang
    Cheng, Ann-Lii
    ONCOLOGY, 2012, 82 (05) : 275 - 289
  • [2] Liver stiffness as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients receiving interferon-based anti-viral therapy
    Narita, Yutaka
    Genda, Takuya
    Tsuzura, Hironori
    Sato, Shunsuke
    Kanemitsu, Yoshio
    Kikuchi, Tetsu
    Hirano, Katsuharu
    Iijima, Katsuyori
    Ichida, Takafumi
    HEPATOLOGY, 2012, 56 : 451A - 451A
  • [3] Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients
    Lin, D.
    Yang, H. -I.
    Nguyen, N.
    Hoang, J.
    Kim, Y.
    Vu, V.
    Le, A.
    Chaung, K.
    Nguyen, V.
    Trinh, H.
    Li, J.
    Zhang, J.
    Hsing, A.
    Chen, C. -J.
    Nguyen, M. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (08) : 846 - 855
  • [4] Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti-viral therapy
    Yip, Terry Cheuk-Fung
    Wong, Vincent Wai-Sun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (05) : 722 - 723
  • [5] Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy
    Narita, Yutaka
    Genda, Takuya
    Tsuzura, Hironori
    Sato, Shunsuke
    Kanemitsu, Yoshio
    Ishikawa, Sachiko
    Kikuchi, Tetsu
    Hirano, Katsuharu
    Iijima, Katsuyori
    Wada, Ryo
    Ichida, Takafumi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 137 - 143
  • [6] Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B
    Singal, A. K.
    Salameh, H.
    Kuo, Y. -F.
    Fontana, R. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (02) : 98 - 106
  • [7] The anti-viral effect of sorafenib in hepatitis C-related hepatocellular carcinoma
    Cabrera, R.
    Limaye, A. R.
    Horne, P.
    Mills, R.
    Soldevila-Pico, C.
    Clark, V.
    Morelli, G.
    Firpi, R.
    Nelson, D. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 91 - 97
  • [8] Estimation of risk for the development of hepatocellular carcinoma after successful eradication of hepatitis C by anti-viral therapy
    Kurosaki, Masayuki
    Tsuchiya, Kaoru
    Yasui, Yutaka
    Tamaki, Nobuharu
    Hosokawa, Takanori
    Izumi, Namiki
    HEPATOLOGY, 2013, 58 : 902A - 902A
  • [9] LIVER STIFFNESS MEASUREMENT AFTER SUCCESSFUL ANTI-VIRAL THERAPY IN HEPATOCELLULAR CARCINOMA RISK ASSESSMENT FOR CHRONIC HEPATITIS C PATIENTS
    Wang, J. -H.
    Yen, Y. -H.
    Hung, C. -H.
    Chen, C. -H.
    Lee, C. -M.
    Lu, S. -N.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S616 - S616
  • [10] Hepatocellular carcinoma development in hepatitis C virus patients who achieved sustained viral response by interferon therapy and direct anti-viral agents therapy
    Nagaoki, Yuko
    Aikata, Hiroshi
    Kobayashi, Tomoki
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Chayama, Kazuaki
    HEPATOLOGY, 2016, 64 : 424A - 424A
12345